Skip to search formSkip to main contentSkip to account menu

chlorhexidine gluconate 2.5 MG Drug Implant

Known as: chlorhexidine gluconate 2.5 MG Oromucosal Chip, chlorhexidine gluconate 2.5 MG Periodontal Drug Implant 
National Institutes of Health

Related topics

Related topics

2 relations
Drug Implant

Narrower (1)

chlorhexidine gluconate 2.5 MG Drug Implant [PerioChip]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
2012
2012
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis
BackgroundSpasticity is common in patients with multiple sclerosis (MS) and is a major contributor to disability. Sativex®, an… 
2010
2010
Cannabis based drug is licensed for spasticity in patients with MS
The first drug derived from the cannabis plant to be granted a licence by UK authorities has been made available for relief of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)